The The LDN Book Volume Two
The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More
$45.04
- Paperback
288 pages
- Release Date
24 September 2020
Summary
A comprehensive examination of Low Dose Naltrexone - a little-known drug with big potential
New drug [LDN] raises hopes of reversing memory loss in old age
A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.
Expandi…
Book Details
| ISBN-13: | 9781603589901 |
|---|---|
| ISBN-10: | 1603589902 |
| Author: | Linda Elsegood |
| Publisher: | Chelsea Green Publishing Co |
| Imprint: | Chelsea Green Publishing Co |
| Format: | Paperback |
| Number of Pages: | 288 |
| Release Date: | 24 September 2020 |
| Weight: | 450g |
| Dimensions: | 31mm x 153mm x 229mm |

You Can Find This Book In
Critics Review
“Since the first volume of The LDN Book was released, I have had the distinct privilege of learning from and collaborating with the best clinicians and researchers in the field of integrative medicine. Through these collaborations, we continue to build upon the already vast applications of this low-dose but high-power medication. I am thrilled to see so many trusted colleagues, who have also become friends, contribute to this important body of work. Thank you, again, Linda Elsegood, for bringing together a tribe of like-minded people who continue to find solutions to challenging medical issues with this simple and inexpensive intervention.”—Dr. Nasha Winters, ND, FABNO, author of The Metabolic Approach to Cancer
“As a pharmacist, I often wish for a ‘miracle’ drug that would be safe, effective, and inexpensive and could help the masses take back their health. While no drug is right for everyone, I have seen LDN transform the lives of countless people with autoimmunity. For some, LDN has truly been a miracle drug. I highly recommend both volumes of The LDN Book as valuable resources for patients and clinicians alike to explore the best practices for using LDN.”—Dr. Izabella Wentz, Pharm.D., FASCP, New York Times bestselling author of Hashimoto’s Protocol
“A fantastic resource. All the latest research on low dose naltrexone and its various uses in clinical practice is compiled in this easy-to-use volume—The LDN Book, Volume 2. I will definitely be keeping this book in my office for reference.”—Jill C. Carnahan, MD, ABIHM, ABoIM, IFMCP
“Even if you think you know about the benefits of LDN for certain conditions through practical experience or otherwise, this book will expand your understanding and amazement. It is a remarkable finding that a drug designed for a specific condition can be applied to so many other systems at lower and lower doses. Interestingly, this has shown us that many other drugs may also have unexpected benefits at lower-than-intended doses. There are many layers of complexity that remain to be uncovered!”—Dr. Angus Dalgleish, professor of oncology, St. George’s, University of London; principal, Institute for Cancer Vaccines and Immunotherapy (ICVI)
“Over the years, a wealth of clinical trials and studies on LDN have given us better information about how and why LDN actually works. Through this research, we have uncovered many new uses of LDN in medical treatment. Reviewing The LDN Book, Volume 2 and seeing how other experts prescribe LDN in their clinics has been a great treat for me. My clinic, Clinic 158, has been prescribing LDN for 12 years. We have thousands of very happy patients who have found success with the medication for a myriad of ailments, and we are still learning new information.”—Dr. Andrew McCall, director, Clinic 158
“Since inflammation is a major contributor to almost all chronic disorders, LDN therapy bridges nearly every medical specialty. In The LDN Book, Volume 2, the authors provide an excellent overview of LDN’s mechanism of action, review the vast evidence base supporting clinical applications, and, most importantly, report actual cases in which LDN was instrumental in the successful treatment of patients. This book is a must-have for every clinician, and LDN should be considered in the treatment of the many disorders outlined therein.”—Sahar Swidan, Pharm.D., R.Ph., ABAAHP, FAARFM, FACA, president and CEO, Pharmacy Solutions
Linda Elsegood
Linda Elsegood is the founder of the LDN Research Trust, a Registered Charity established in the UK in 2004. She also serves as the editor of The LDN Book Volumes 1 and 2.
After her diagnosis with Multiple Sclerosis (MS) in August 2000, Linda began LDN therapy in December 2003. She reports experiencing an improved quality of life and a renewed sense of hope for the future since starting this treatment.
Through the LDN Research Trust, Linda has connected numerous patients, doctors, and pharmacists globally, providing them with access to information, articles, and patient testimonials about LDN. She has also played a role in organizing conferences, seminars, and the Trust’s LDN Radio Show.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.



